loadpatents
name:-0.0096859931945801
name:-0.0069370269775391
name:-0.0034987926483154
Aceto; Nicola Patent Filings

Aceto; Nicola

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aceto; Nicola.The latest application filed is for "na+/k+ atpase inhibitors for use in the prevention or treatment of metastasis".

Company Profile
2.6.10
  • Aceto; Nicola - Reinach CH
  • Aceto; Nicola - Monferrato IT
  • ACETO; Nicola - Basel CH
  • Aceto; Nicola - Casale Monferrato N/A IT
  • Aceto; Nicola - Casalo Monferrato AL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Device and method for comminution of circulating tumor cell clusters
Grant 11,452,543 - Aceto , et al. September 27, 2
2022-09-27
Methods relating to circulating tumor cell clusters and the treatment of cancer
Grant 11,421,233 - Aceto , et al. August 23, 2
2022-08-23
Na+/k+ Atpase Inhibitors For Use In The Prevention Or Treatment Of Metastasis
App 20220062317 - ACETO; Nicola ;   et al.
2022-03-03
Device And Method For Comminution Of Circulating Tumor Cell Clusters
App 20210196309 - Aceto; Nicola ;   et al.
2021-07-01
Methods Relating To Circulating Tumor Cell Clusters And The Treatment Of Cancer
App 20200392505 - ACETO; Nicola ;   et al.
2020-12-17
Methods relating to circulating tumor cell clusters and the treatment of cancer
Grant 10,731,162 - Aceto , et al.
2020-08-04
Methods Relating To Circulating Tumor Cell Clusters And The Treatment Of Cancer
App 20180320185 - ACETO; Nicola ;   et al.
2018-11-08
Methods relating to circulating tumor cell clusters and the treatment of cancer
Grant 10,053,692 - Aceto , et al. August 21, 2
2018-08-21
Methods Relating To Circulating Tumor Cell Clusters And The Treatment Of Cancer
App 20160264973 - ACETO; Nicola ;   et al.
2016-09-15
Method of treatment of breast cancers over-expressing the SHP2 signature genes
Grant 9,181,553 - Bentires-Alj , et al. November 10, 2
2015-11-10
Inhibition Of Interleukin-8 And/or Its Receptor Cxcr1 In The Treatment Of Her2/her3-overexpressing Breast Cancer
App 20150266961 - Bentires-Alj; Mohamed ;   et al.
2015-09-24
Protein Tyrosine Phosphatase, Non-receptor Type 11 (ptpn11) And Triple-negative Breast Cancer
App 20140134184 - Bentires-Alj; Mohamed ;   et al.
2014-05-15
Protein Tyrosine Phosphatase, Non-receptor Type 11 (ptpn11) And Tumor Initiating Cells
App 20130028886 - Aceto; Nicola ;   et al.
2013-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed